Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis

Journal of Hepatology

Volumn 6, Issue 3, 1988, Pages 350-358

  Tage Jensen, U ^a   Henriksen, J H ^a   Christensen, E ^a   Widding, A ^a   Ring Larsen, H ^a   Christensen, N Juel ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; INDOCYANINE GREEN;

ADRENERGIC SYSTEM; ADULT; ALCOHOL LIVER CIRRHOSIS; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; EPINEPHRINE; FEMALE; HUMAN; ISOELECTRIC POINT; LIVER CIRRHOSIS; MALE; MIDDLE AGE; NOREPINEPHRINE; PORTAL VEIN; PROGNOSIS; VENOUS PRESSURE;

EID: 0023904786     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(88)80053-9     Document Type: Article

References (47)

1. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis
2. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites
3. Valeur pronostique du système rénineangiotensine dans la réponse à la restriction sodique et le pronostic de l'ascite cirrhotique d'origine alcoolique
4. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis
5. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction and renal release
6. Role of the splanchnic bed in extracting circulating adrenaline and noradrenaline in normal subjects and in patients with cirrhosis of the liver
7. Sympathetic nervous activity in cirrhosis. A survey of plasma catecholamine studies
8. Prognostic factors in cirrhotics with ascites
9. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
10. Copenhagen Study Group for Liver Disease. Liver haemodynamics and function in alcoholic cirrhosis. Relation to testosterone treatment and ethanol consumption
11. Whole body clearance of norepinephrine. The significance of arterial sampling and surgical stress
12. Cerebrospinal fluid adrenaline and noradrenaline in depressed patients
13. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with cirrhosis
14. Hepatic blood flow determination
15. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man
16. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
17. Regression models and life tables (with discussion)
18. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial
19. Multivariate survival analysis using Cox's regression model
20. Multivariate prediction of coronary heart disease during 8.5 year follow-up in the western collaborative group study
21. Analysis of Survival Data under the Proportional Hazards Model
22. Issues in Multiple Regression
23. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone
24. Sclerotherapy after First Variceal Hemorrhage in Cirrhosis
25. Norepinephrine, hormone and neurotransmitter in man
26. Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease. Plasma noradrenaline, splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise
27. Serial determination of plasma catecholamines in myocardial infarction
28. Enhanced sympathetic nervous activity in patients with chronic obstructive lung disease
29. Changes of circulatory noradrenaline and adrenaline in hepatic cirrhosis. Relation to stage of disease, liver and renal function
30. 2 in cirrhosis. Relation to functional renal failure and sodium and water excretion
31. Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Associations with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion
32. Total and renal sympathetic nervous system activity in alcoholic cirrhosis
33. Hepatic-intestinal uptake and release of catecholamines in alcoholic cirrhosis. Evidence of enhanced hepatic-intestinal sympathetic nervous activity
34. Sympathetic tone modulates portal venous pressure in alcoholic cirrhosis
35. Circulating noradrenaline and central haemodynamics in patients with cirrhosis
36. Substance P is markedly increased in plasma of patients with hepatic coma
37. Function of the autonomic nervous system in patients with hepatic encephalopathy
38. Portal venous content of adrenaline and noradrenaline in portal hypertension
39. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture
40. Portal hypertension, size of esophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis
41. Clinical and prognostic significance of porto-hepatic gradient in patients with cirrhosis
42. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment
43. Prognostic indicators in alcoholic cirrhotic men
44. The varix volcano connection
45. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables
46. Use of a prognostic index in assessment and outcome of liver transplantation in patients with primary biliary cirrhosis